Back to User profile » Dr Rong Wang

Papers published by Dr Rong Wang:

Original Research

Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method

Yang G, Li Z, Wu F, Chen M, Wang R, Zhu H, Li Q, Yuan Y

International Journal of Nanomedicine 2020, 15:1661-1675

Published Date: 10 March 2020

Original Research

Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways

Wang R, Song F, Li S, Wu B, Gu Y, Yuan Y

Drug Design, Development and Therapy 2019, 13:1889-1900

Published Date: 31 May 2019

Original Research

Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides

Yang G, Wu F, Chen M, Jin J, Wang R, Yuan Y

International Journal of Nanomedicine 2019, 14:2267-2280

Published Date: 1 April 2019

Original Research

Asiatic acid ameliorates CC l4-induced liver fibrosis in rats: involvement of Nrf2/ARE, NF-κB/IκBα, and JAK1/STAT3 signaling pathways

Fan J, Chen Q, Wei L, Zhou X, Wang R, Zhang H

Drug Design, Development and Therapy 2018, 12:3595-3605

Published Date: 26 October 2018

Original Research

Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling

Wang YY, Wang R, Wang YJ, Peng RQ, Wu Y, Yuan YF

Drug Design, Development and Therapy 2015, 9:6303-6317

Published Date: 3 December 2015